Novel vaccines: bridging research, development and production - CHI's Inaugural Conference.
Ulmer
Jeffrey B
JB
Novartis Vaccines & Diagnostics, CA 94608-2916, USA. jeffrey_ulmer@chiron.com
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D004337:Drug Carriers; D019143:Evolution, Molecular; D005822:Genetic Vectors; D006360:Heat-Shock Proteins / Q000627:therapeutic use*; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology; D014020:Tissue Extracts / Q000627:therapeutic use*; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D019496:Cancer Vaccines; D004337:Drug Carriers; D006360:Heat-Shock Proteins; D007252:Influenza Vaccines; D014020:Tissue Extracts; D014612:Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; C484813:vitespin; C511774:sipuleucel-T